We undertook the present study to determine the mechanism of EGFRvIII expression in HNSCC, with the ultimate goal of optimizing treatment approaches for HNSCC tumors that harbor this EGFR variant. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.